Global Wound Care Biologics Market

Wound Care Biologics Market Size, Share, Growth Analysis, By Product(Biological Skin Substitutes and Topical Agents), By End user(Hospitals/Clinics, Ambulatory Surgical Centers, and Other End Users), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2221 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 61 |Figures: 75

Wound Care Biologics Market Insights

Wound Care Biologics Market size was valued at USD 2.2 Billion in 2021 and is poised to grow from USD 2.40 Billion in 2022 to USD 4.90 Billion by 2030, at a CAGR of 9.3% during the forecast period (2023-2030).

The global wound care biologics market is experiencing significant growth and development, driven by various factors and technological advancements in the healthcare sector. Wound care biologics, which include various biological substances like growth factors, cytokines, and stem cells, offer innovative solutions to promote wound healing and tissue regeneration. These biologics have gained popularity due to their effectiveness in treating chronic wounds, diabetic foot ulcers, and burns, among other complex wounds. Additionally, the increasing prevalence of chronic diseases and rising geriatric population, which are more susceptible to slow-healing wounds, have further boosted the demand for wound care biologics. Furthermore, the shift towards personalised medicine and the emphasis on advanced wound care therapies have encouraged healthcare providers to adopt biologics for improved patient outcomes. The focus on reducing hospital stays and healthcare costs has also steered the market towards more efficient and effective wound care solutions, which has further driven the demand for biologics. Despite the significant growth opportunities, the global wound care biologics market faces some challenges.

One of the key challenges is the high cost associated with these advanced therapies, making them less accessible to a considerable portion of the population. Additionally, strict regulatory requirements and the need for specialised facilities for biologics production and storage may hinder market growth. Moreover, the availability of alternative wound care products and treatments, such as traditional dressings and antimicrobial agents, may pose a challenge to the widespread adoption of wound care biologics. The limited awareness about biologic wound care options among healthcare professionals and patients in some regions may also impact market growth.

US Wound Care Biologics Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 2.2 Billion

Largest Segment

Biological skin substitute

Fastest Growth

Biological skin substitute

Growth Rate

9.3% CAGR

Global Wound Care Biologics Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Wound Care Biologics Market Segmental Analysis

The global wound care biologics market is segmented on the basis of product, end user, and region. By product, the market is segmented into Biological Skin Substitutes and Topical Agents. By end user, the market is segmented into Hospitals/Clinics, Ambulatory Surgical Centers, and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Wound Care Biologics Market Analysis By Product

The global wound care biologics market can be analysed by product segment, with two significant categories being Biological Skin Substitutes and Topical Agents. Biological Skin Substitutes, also known as cellular or tissue-based products, are a dominant segment in the wound care biologics market. These substitutes are designed to replace or aid in the regeneration of damaged or lost skin tissues. They offer an advanced approach to wound healing, promoting cellular growth and tissue repair, making them highly effective in treating chronic wounds, burns, and complex injuries. The demand for Biological Skin Substitutes is driven by their ability to accelerate wound closure, reduce scarring, and improve overall wound healing outcomes.

On the other hand, Topical Agents are emerging as the fastest-growing segment in the global wound care biologics market. These agents include growth factors, cytokines, and enzymes that are applied directly to the wound site to stimulate cellular activity and enhance the natural healing process. Topical Agents offer a more accessible and cost-effective solution for wound care, making them increasingly popular among healthcare professionals and patients alike. The ease of application and their ability to treat a wide range of wound types, from acute to chronic, contribute to the rapid growth of this segment.

Wound Care Biologics Market Analysis of End user

The global wound care biologics market can be segmented by end users into Hospitals/Clinics, Ambulatory Surgical Centers, and Other End Users. Hospitals/Clinics represent the dominant end-user segment in the wound care biologics market. These healthcare facilities serve as primary destinations for patients requiring wound care management, especially for complex wounds and chronic conditions. Hospitals and clinics have well-established wound care units with specialised healthcare professionals who are adept at utilising biologics to accelerate wound healing and achieve better patient outcomes. The high patient footfall and the growing demand for advanced wound care treatments in hospital settings contribute to the dominance of this segment.

On the other hand, Ambulatory Surgical Centers (ASCs) are emerging as the fastest-growing end-user segment in the global wound care biologics market. ASCs offer outpatient surgical procedures, including wound care interventions, in a more convenient and cost-effective setting compared to traditional hospital settings. With advancements in wound care biologics and techniques, many wound healing procedures that once required hospitalisation can now be efficiently performed in ASCs. The growing popularity of Ambulatory Surgical Centers is fueled by their ability to provide high-quality wound care services while reducing healthcare costs and the length of hospital stays for patients.

Global Wound Care Biologics Market By Product, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Wound Care Biologics Market Regional Insights

North America holds a dominant position in the global wound care biologics market. The region's dominance can be attributed to well-established healthcare infrastructure, a high prevalence of chronic wounds, and a strong focus on adopting advanced wound care solutions. Additionally, the presence of key market players and extensive research and development activities further contribute to North America's leading position in the wound care biologics market.

Asia Pacific is emerging as the fastest-growing region in the global wound care biologics market. The region's growth is fueled by increasing healthcare expenditure, a large patient population, and rising awareness about advanced wound care options. Moreover, the rapid development of healthcare facilities and the growing adoption of technologically advanced wound care products in countries like India and China are driving the demand for wound care biologics in the Asia Pacific region.

Global Wound Care Biologics Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Wound Care Biologics Market Dynamics

Wound Care Biologics Market Drivers

Rising Prevalence of Chronic Wounds

  • The increasing incidence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is a significant driver for the wound care biologics market. Biologic wound care products offer advanced therapeutic options for promoting wound healing in challenging cases.

Growing Geriatric Population

  • The aging population is more prone to slow-healing wounds, and as the global elderly population expands, the demand for effective wound care biologics is expected to rise.

Wound Care Biologics Market Restraints

Stringent Regulatory Requirements

  • The rigorous regulatory approval process for biologic wound care products can delay their market entry and increase development costs for manufacturers.

Limited Awareness and Accessibility

  • Lack of awareness among healthcare professionals and patients about wound care biologics, especially in developing regions, may hinder market growth.

Request Free Customization of this report to help us to meet your business objectives.

Wound Care Biologics Market Competitive Landscape

The global wound care biologics market is characterised by a competitive landscape, with several key players vying for market share. These players focus on research and development to introduce innovative biologic wound care products that cater to various wound types and patient needs. The market is witnessing strategic collaborations, partnerships, and mergers and acquisitions to expand their product portfolios and strengthen their market presence. Additionally, companies are investing in marketing and promotional activities to increase awareness among healthcare professionals and patients about the benefits of wound care biologics. The market is also witnessing the entry of new players, further intensifying competition. Apart from established companies, there are numerous small and medium-sized enterprises that contribute to the overall competitiveness of the wound care biologics market.

As the demand for advanced wound care solutions continues to grow, players in the market are keenly focused on offering cost-effective and efficient wound care biologics to gain a competitive edge in the global marketplace. The competition is likely to remain intense, with companies striving to meet the evolving needs of patients and healthcare providers, while complying with regulatory standards and maintaining ethical considerations in their products and operations.

Wound Care Biologics Market Top Player’s Company Profile

  • Acelity L.P. Inc. (KCI) - US
  • Organogenesis Inc. - US
  • Stryker Corporation - US
  • Osiris Therapeutics, Inc. - US
  • ACell, Inc. - US
  • Vericel Corporation - US
  • Coloplast Group - Denmark
  • Medline Industries, Inc. - US
  • ConvaTec Group Plc - United Kingdom
  • Ethicon, Inc. (a subsidiary of Johnson & Johnson) - US
  • Anika Therapeutics, Inc. - US
  • Kerecis - Iceland
  • 3M Company - US
  • Baxter International Inc. - US
  • Johnson & Johnson - US
  • MiMedx Group, Inc. - US
  • Solsys Medical - US

Wound Care Biologics Market Recent Developments

  • In July 2022, Tides Medical launched a new product, Artacent AC, a tri-layer skin graft designed for use in the treatment of complex or difficult-to-treat wounds.

Wound Care Biologics Key Market Trends

  • Shift towards Personalised Medicine: There has been a shift towards personalised medicine in wound care, with a focus on tailoring treatments based on individual patient needs and wound characteristics. Wound care biologics play a vital role in providing personalised wound healing solutions.
  • Technological Advancements: Continuous advancements in biotechnology and wound care research have led to the development of more effective and innovative wound care biologics. Companies are investing in research and development to introduce new products with enhanced efficacy and safety profiles.

Wound Care Biologics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our global Wound Care Biologics market analysis, North America dominates the market with its advanced healthcare infrastructure and substantial patient base, Asia Pacific's fastest-growing status is fueled by its dynamic healthcare landscape and increasing investments in wound care biologics. The global wound care biologics market has witnessed significant growth and transformation in recent years. With an increasing prevalence of chronic wounds and a growing aging population, the demand for advanced wound care solutions has soared. Wound care biologics, such as cellular and tissue-based products, have emerged as promising therapeutic options, offering regenerative and tissue-healing benefits. Technological advancements in biotechnology have led to the development of innovative wound care biologics with improved efficacy and safety profiles. Moreover, the shift towards personalised medicine has paved the way for tailored wound care treatments, catering to individual patient needs. The market has also seen a surge in awareness among healthcare professionals and patients regarding the benefits of advanced wound care, contributing to higher adoption rates. As companies focus on cost-effectiveness, sustainability, and ethical practices, the wound care biologics market is witnessing a dynamic landscape with strategic collaborations and partnerships shaping its future. While the market continues to evolve, it holds promising opportunities for growth and innovation, empowering healthcare providers to offer better wound healing outcomes and improving the quality of life for patients with chronic and complex wounds worldwide.

Report Metric Details
Market size value in 2023 USD 2.2 Billion
Market size value in 2031 USD 4.90 Billion
Growth Rate 9.3%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Biological Skin Substitutes and Topical Agents
  • End user
    • Hospitals/Clinics, Ambulatory Surgical Centers, and Other End Users
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Acelity L.P. Inc. (KCI) - US
  • Organogenesis Inc. - US
  • Stryker Corporation - US
  • Osiris Therapeutics, Inc. - US
  • ACell, Inc. - US
  • Vericel Corporation - US
  • Coloplast Group - Denmark
  • Medline Industries, Inc. - US
  • ConvaTec Group Plc - United Kingdom
  • Ethicon, Inc. (a subsidiary of Johnson & Johnson) - US
  • Anika Therapeutics, Inc. - US
  • Kerecis - Iceland
  • 3M Company - US
  • Baxter International Inc. - US
  • Johnson & Johnson - US
  • MiMedx Group, Inc. - US
  • Solsys Medical - US
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Wound Care Biologics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Wound Care Biologics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Wound Care Biologics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Wound Care Biologics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Wound Care Biologics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Wound Care Biologics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Wound Care Biologics Market size was valued at USD 2.2 Billion in 2021 and is poised to grow from USD 2.40 Billion in 2022 to USD 4.90 Billion by 2030, at a CAGR of 9.3% during the forecast period (2023-2030).

The wound care biologics market is characterised by a competitive landscape, with several key players vying for market share. These players focus on research and development to introduce innovative biologic wound care products that cater to various wound types and patient needs. The market is witnessing strategic collaborations, partnerships, and mergers and acquisitions to expand their product portfolios and strengthen their market presence. Additionally, companies are investing in marketing and promotional activities to increase awareness among healthcare professionals and patients about the benefits of wound care biologics. The market is also witnessing the entry of new players, further intensifying competition. Apart from established companies, there are numerous small and medium-sized enterprises that contribute to the overall competitiveness of the wound care biologics market. 'Acelity L.P. Inc. (KCI) - US', 'Smith & Nephew plc - UK', 'Mölnlycke Health Care AB - Sweden', 'Integra LifeSciences Corporation - US', 'Organogenesis Inc. - US', 'Stryker Corporation - US', 'Osiris Therapeutics, Inc. - US', 'ACell, Inc. - US', 'Vericel Corporation - US', 'Coloplast Group - Denmark', 'Medline Industries, Inc. - US', 'ConvaTec Group Plc - United Kingdom', 'Ethicon, Inc. (a subsidiary of Johnson & Johnson) - US', 'Anika Therapeutics, Inc. - US', 'Kerecis - Iceland', '3M Company - US', 'Baxter International Inc. - US', 'Johnson & Johnson - US', 'MiMedx Group, Inc. - US', 'Solsys Medical - US'

The increasing incidence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, is a significant driver for the wound care biologics market. Biologic wound care products offer advanced therapeutic options for promoting wound healing in challenging cases.

Shift towards Personalised Medicine: There has been a shift towards personalised medicine in wound care, with a focus on tailoring treatments based on individual patient needs and wound characteristics. Wound care biologics play a vital role in providing personalised wound healing solutions.

North America holds a dominant position in the wound care biologics market. The region's dominance can be attributed to well-established healthcare infrastructure, a high prevalence of chronic wounds, and a strong focus on adopting advanced wound care solutions. Additionally, the presence of key market players and extensive research and development activities further contribute to North America's leading position in the wound care biologics market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Wound Care Biologics Market

Product ID: SQMIG35H2221

$5,300
BUY NOW GET FREE SAMPLE